[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-INBX":3,"homepage-market-summary":31,"stock-news-INBX":175},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"INBX","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Inhibrx Biosciences, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.","110","La Jolla, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},94.56,97.56,98.5054,94.18,96.99,-2.43,-2.51,206566.080506,6636,95.6618,155.28999,28.16,340032.21861718723,52.2,1539,{"status":32,"indices":33,"watchlist":78,"sectors":100,"benchmarks":154},"success",[34,43,50,57,64,71],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":42},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8","2026-10-02",{"symbol":44,"name":45,"price":46,"change":47,"pct_change":48,"is_up":40,"sparkline":49,"date":42},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":51,"name":52,"price":53,"change":54,"pct_change":55,"is_up":40,"sparkline":56,"date":42},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":58,"name":59,"price":60,"change":61,"pct_change":62,"is_up":40,"sparkline":63,"date":42},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":65,"name":66,"price":67,"change":68,"pct_change":69,"is_up":40,"sparkline":70,"date":42},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":72,"name":73,"price":74,"change":75,"pct_change":76,"is_up":14,"sparkline":77,"date":42},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[79,86,93],{"symbol":80,"name":81,"price":82,"change":83,"pct_change":84,"is_up":40,"sparkline":85,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":87,"name":88,"price":89,"change":90,"pct_change":91,"is_up":14,"sparkline":92,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":94,"name":95,"price":96,"change":97,"pct_change":98,"is_up":40,"sparkline":99,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[101,106,110,115,120,125,130,135,140,145,149],{"name":102,"etf":103,"change":104,"price":105,"is_up":40},"Technology","XLK",0.56,200.93,{"name":107,"etf":108,"change":39,"price":109,"is_up":40},"Financials","XLF",53.88,{"name":111,"etf":112,"change":113,"price":114,"is_up":40},"Healthcare","XLV",0.72,167.37,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",0.35,110.42,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.63,81.04,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.99,63.44,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.09,170.1,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",1.31,49.5,{"name":141,"etf":142,"change":143,"price":144,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":146,"etf":147,"change":118,"price":148,"is_up":40},"Utilities","XLU",39.97,{"name":150,"etf":151,"change":152,"price":153,"is_up":40},"Comm Services","XLC",1.17,111.61,[155,160,165,170],{"ticker":156,"name":157,"price":158,"change":159,"is_up":40},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":161,"name":162,"price":163,"change":164,"is_up":40},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":166,"name":167,"price":168,"change":169,"is_up":40},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":171,"name":172,"price":173,"change":174,"is_up":40},"IWM","iShares Russell 2000",283.39,0.66,{"ticker":4,"count":176,"articles":177},19,[178,184,190,195,201,207,213,218,224,229,235,241,247,252,257,262,267,272,277],{"title":179,"link":180,"pubDate":181,"description":182,"source":183},"Inhibrx Stock Price Forecast. Should You Buy INBX? - StockInvest.us","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiSEFVX3lxTE1kclhsU2xMcHc0X1Bzd2wtZF9TazhCejZQck5ycFpDVkpONTg0VHBWR283MjZNbVExZ1pDVDhuMXJxY2NQRHQwbg?oc=5","Fri, 02 Oct 2026 22:22:43 GMT","Inhibrx Stock Price Forecast. Should You Buy INBX? StockInvest.us","StockInvest.us",{"title":185,"link":186,"pubDate":187,"description":188,"source":189},"$INBX stock is down 11% today. Here's what we see in our data. - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxPYmY5ZXhTNjQwTk1nS3A0cTV4Vm01ZWd3cUZsRlZ1MTl1dnBqRVU1b1hlYklSLXZrMThCWGc1QXBKaGw5S1Q2S1BiV0FWTlJtNUgzZENxeGEtTkRpeHVkM3o5bzhBQ3VKRDJ4YXZNYVBORXAyWUxqSDQtdFR5bUhTQ2dMdGJCMUxTaHUtWXA0VlBwNlZyUG5OS3N1WGM1b0FZd3RF?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","$INBX stock is down 11% today. Here's what we see in our data. Quiver Quantitative","Quiver Quantitative",{"title":191,"link":192,"pubDate":187,"description":193,"source":194},"At $100 a share, a director's family trust bought 5,000 shares of Inhibrx Biosciences (INBX). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxPU0NyWDJTQm94X0FWLWpBYVNmNDVjUkxNd3IxdVdqMlhKX1VOaTBYWEFBVUk0UE9zR3RpZ2gzdVdaeWlPXy1ibGxJbFpKNExGMl9vRGxGRnNzejJiRjBSTzBLM3BfRVg0VWR5akxiRW9sODFkMTlWRllGc0RXYUh2Ujk1S2JMRVZ5UWxkdWNPQXJTZXJqSWszYThGZkJ3SFFfZnFtb1MtLWpReUE1a0twRXJOTEZNWHNZ?oc=5","At $100 a share, a director's family trust bought 5,000 shares of Inhibrx Biosciences (INBX). Stock Titan","Stock Titan",{"title":196,"link":197,"pubDate":198,"description":199,"source":200},"Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Tue, 29 Sep 2026 15:15:03 GMT","Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now? Simply Wall Street","Simply Wall Street",{"title":202,"link":203,"pubDate":204,"description":205,"source":206},"Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall? - finance.yahoo.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxQc09CbFY3bndtZ2tqaE00d3c0TDA1R1lBNHNlbXVvMFRMeVVRTllBcWs0VXlSQVBxdWgyMkd3RlF0Y2RGcjdKdnQ2YV9WeGtpcGYwOFM2SURnbUpRS09RWkJIdC1xQU9wOF9VNGJ3RjE0TURjdEJXMFd6ZGdxTGRMNzFBbDA4U0N1V1kzcndfd2g3YWZNci11N1BqTQ?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall? finance.yahoo.com","finance.yahoo.com",{"title":208,"link":209,"pubDate":210,"description":211,"source":212},"Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxON2hFMEdyRWNmcnNhRmdzWFE0a0tiQ0xLQ2FiOWtGWTdtdUpseDBiTGJzRnhoSng4Slc5RlU2QXJSM3pUNjdVMnlZNWNpWG4weVp0QUs2VE1wa3ZTYmFSZDhiNVRvX21wREVjLXpZTzhsN3hjZXBfSTNnYUVPRUg5TUtCbzg1NjBjVXdPaGNnUmFldXZqRGZ6OTR6c01LeHBpMEd6Tm81R3F0TTZqSUE?oc=5","Fri, 02 Oct 2026 12:10:50 GMT","Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup MarketBeat","MarketBeat",{"title":214,"link":215,"pubDate":216,"description":217,"source":194},"Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxPVER0R0F1bFRFNGJmWnFERkRaSmtyOE1LcUlfR3hjOHJzNWdyMlJiOGlVM3BDWUpKYjhuajN1cjNKdU02NWc5MDBnRTB3S2NIZ0pHVnpSTVAyYVhrU3BXa0tyR1hLU0hreEFVYk5lRHBuUXhFUzVyREJ6X0Ixcm1JQVpZX2tBX2JkQVM0Z1Z2eW1tQUNTR1lqNGtrODB1ak9pREVxRF9NQklDWFVwY1VHMG1Xc0Z6SFlK?oc=5","Mon, 28 Sep 2026 21:48:57 GMT","Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. Stock Titan",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxNZVNQcFBhNER0NXpVT2pJR0xBUC1YSmt1QzlKX19MdHdNQVI0dF9nMExjY1Fzd0d1U0NlZWt1Y3MxZW5QRVptSFNqYmtGOTFYMUk3TmNZNkJqOXdZTmRVUmN2WlE3SjBLd1RkZFJoNnZVWS1WZVoxRWVUQ1NsOG9wQU8wdDdVMVV5dXdRMDZ4YUxyWG1JbnZlWEdzWE9qSmQ3SDF1ZmVrTURnNGo4Q2xFU2Uzb2N6d2VXaHpQc1YxcUdOQ0U0?oc=5","Mon, 28 Sep 2026 22:49:35 GMT","Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock Investing.com","Investing.com",{"title":225,"link":226,"pubDate":227,"description":228,"source":206},"Inhibrx Biosciences (INBX) Faces A Pipeline Valuation Test Following Its Sharp Rerating - finance.yahoo.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxNRUxoQURNZW5RaTRZZnBWcXVRbEx2S18wd2lDdXlIdmphbFBYTlZBcWJrcHFvNFM3Ry1YNDE1LWZFdXItVDlZX3hvOHRkdjZKOGxSdjZVY2tzYk5qQlh0TGY3XzUzUU9JRUhsUjZjTnRlNFpzYXgwc05CajZNZVV2bFJaSmhyMmZHcC1SUFE3T0RKLTRSVjNwajhlQnR0dXY0UGdXSUtmRQ?oc=5","Tue, 29 Sep 2026 11:08:51 GMT","Inhibrx Biosciences (INBX) Faces A Pipeline Valuation Test Following Its Sharp Rerating finance.yahoo.com",{"title":230,"link":231,"pubDate":232,"description":233,"source":234},"Inhibrx Biosciences stock gains on insider buying and trial progress - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxOWmlHbHJmOU9aWTNYWDljazFkUV8xYlJiNDRzT0tjc2tWNW9lMzFfQ2hvTFZ0dUx5ekg5eXo3QmZrOVJFRE5BRjFsNFZCVWdySk5USUFOZ3JhSXRseDR0TEh2RlNvMnBiTGxnc3dxemFUUDAwUnhlRGttM0x2ZTRKNUk5d0pxd0QzR1ZaZVF5cmk0bllqb2tZdnp4cFJfLWFFWXJEb3hTUU9IaG9FcUJxWTVxRUFhbzBPS2VjQ2JFTmFGVjNoLXc?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","Inhibrx Biosciences stock gains on insider buying and trial progress AD HOC NEWS","AD HOC NEWS",{"title":236,"link":237,"pubDate":238,"description":239,"source":240},"Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxQbUR2ME1MYkE1SnNTbTg3SUp6ZGlPYWZWZTk2VDh5ZXhvaS1YN2x1MzBXSzMwdWlaR3Z0Sy1YckdtOUFxUDZLMVh2OUt3NTQtWkNlekRKRHg4X0YwOXgyRDRjZHBvUUN6OHk4a3JLd0hkSjU5Z1p4dGNzMFpvbTlSR25aWnhHOTdxMDdfR0FiRlJqcFA1NFRrQ0RmbE93a2lxSnBXUURqMzZSZ1BmcHpRZEhfVUw3OUZhbmhsLTNCZDFYeGlRQlpKREptSHlCbUZMZ2tCTGsyQm8?oc=5","Wed, 23 Sep 2026 21:02:33 GMT","Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing marketscreener.com","marketscreener.com",{"title":242,"link":243,"pubDate":244,"description":245,"source":246},"INBX Oct 2026 90.000 put (INBX261016P00090000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTE5WM3dqNlliU1BQVC1pNklmdy1sQkRiamVRYXR5LWdDQ1VLZmtZOG81N0VqZElleGh0Vkc5bzJxY2xvQnRBNk1BM01PMzRLcDZGZEp6aDUzLTV4aHNBX044TlFnVWlSUQ?oc=5","Wed, 30 Sep 2026 14:57:20 GMT","INBX Oct 2026 90.000 put (INBX261016P00090000) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":248,"link":249,"pubDate":250,"description":251,"source":194},"A bone cancer drug met its trial goal for Inhibrx Biosciences (INBX), delaying progression versus placebo. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxQWVRYUFhENU9nXzRNd3YzZzNUSktpLVU4R2l4SEFlNkd2RU1EZTYyM29MTlUyMzFuZGJwdGVmM1Fsd1NDaUJWVk40Z3U2SFloekpwNUExSEI1QVhrTVNEdjFXRlFWU3ZzVm5VZlRUam1jN0dXSko1d18tTEN2SE51SG5IZEFpZ05RX0FLaDF2NlR2ZU5jV3pyMHlLbFhEOVgwNEZRNDRkam52LXhPWlhGM0Rn?oc=5","Mon, 28 Sep 2026 21:04:48 GMT","A bone cancer drug met its trial goal for Inhibrx Biosciences (INBX), delaying progression versus placebo. Stock Titan",{"title":253,"link":254,"pubDate":255,"description":256,"source":234},"Inhibrx updates pipeline data as analysts rate Inhibrx stock Moderate Buy - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxPVFVEN0drTWduM1FVd1BRTHVUYzB4czVvelpIeTlmT2hnYU1pek0yYzR4MHJmQ05QTVh3UUxNbUtpZGJ3SUZmWVRvNm9WUXNWRDFtbXBtaW5ieWo4T29URXh3eTRGS1ZhbHIzQk1iWi1PbGs3U0c0NEtoQ0tMdlhQcGtVclZxQ0xERjdlWjNtcllMM0JOYjQyc1p2azVRQk1WdGlLLW9iMlR1SEJBY0RWNFo1Y2xSMENxVEVPcWNUbGRFYjJzclpDQ2E0eEw?oc=5","Mon, 05 Oct 2026 11:38:22 GMT","Inhibrx updates pipeline data as analysts rate Inhibrx stock Moderate Buy AD HOC NEWS",{"title":258,"link":259,"pubDate":260,"description":261,"source":246},"CPB,AHRT,NPWR,BSIN,INBX,VRSK,AMPG | Stock Prices | Quote Comparison - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiekFVX3lxTE5LbUxQRzZYQ1Q3U1c1aFFHQnFrSHB4OTNjWUJpNEJwY08yb016Y183c3pKeDZEZVY0Vng0MUpXUmtQMXBQQTRxMzctSWlveVZtTWlfd2dCU3ZvdUMwN3dDQUpXUTNpaU8zYVhUZElyZm1mQUZqSjBUX01R?oc=5","Thu, 01 Oct 2026 10:27:29 GMT","CPB,AHRT,NPWR,BSIN,INBX,VRSK,AMPG | Stock Prices | Quote Comparison Yahoo! Finance Canada",{"title":263,"link":264,"pubDate":265,"description":266,"source":234},"Inhibrx Biosciences stock falls 1.62 percent on October 5 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQaWRoWTdjVGtzcVVrc1VTb1dlUUs1a2dieGlVOGVxaV9tTGQxNHZVMlNoTnRMclFMRWw2YlE0Wlp0V1paZGE5cUtvWDFFV2pnZGtLOWhRc1ZpUkVlcXc4WDFKcHBhLWw3LVpQQ0JHRGYwaF9TZ1RuVFI2NFgzQkxMSjFHUDV2R2wzTTdWeFpQSkVBSk14cENKNHc1UFZIaXI0cmZpcHN5TXJQdk1IUUFPTjIzQUpzdkhpWXVzOQ?oc=5","Mon, 05 Oct 2026 15:19:22 GMT","Inhibrx Biosciences stock falls 1.62 percent on October 5 AD HOC NEWS",{"title":268,"link":269,"pubDate":270,"description":271,"source":234},"Inhibrx Biosciences stock reports stronger cancer study data - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxPSHJiVzJCeTc1Rk5QT1NlYmpQSGgzQXVwSXZCN1ZCX2RWZmFmT09PbVlXbjZRVXlBVE1tRDF5VnQzQXRMUFNjV2dtdHlkWTQ5V285OXk3Y21qX1RLNGJRc0F6ejFBOEw5TkxKWV8yVkZQbmdDSUloRWZqeGdIVkw5ZVkyNUo2cDZHUFNpOXNsV041eFZZRXFGOUtzMjFlVTUxd3JJMUNNeWNEdVhRQ0l3eGpjZ1VkVHUyVnNn?oc=5","Fri, 25 Sep 2026 12:33:40 GMT","Inhibrx Biosciences stock reports stronger cancer study data AD HOC NEWS",{"title":273,"link":274,"pubDate":275,"description":276,"source":234},"Inhibrx Biosciences stock gets a Moderate Buy consensus at USD 197.50 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxPaUpZUHhlQi0yM2NBZFpYYXl3cnY4bVItcVh0ZlJpU1VFMEV6dFE5Tkg1N1FBdFZTR0w2bVprbUhta2tnTk9WZ09aZDN2cmZTVmhWWi1EWTVSUTZWaXFMT3lkNm1lSWdJQmlRTVRMa0pzUUVQUEhadFZJeUhibzgxNEFpZGNqdG96aDU4clZlNTN4VXgzN3dqb25TS1VhYy1fcjZ2OXlEanhEU2FtYTJ4dVliX3VsU2NweGxXeHR5eGUzekxPODF2MHZXcDU?oc=5","Sun, 04 Oct 2026 10:52:50 GMT","Inhibrx Biosciences stock gets a Moderate Buy consensus at USD 197.50 AD HOC NEWS",{"title":278,"link":279,"pubDate":280,"description":281,"source":282},"Inhibrx Biosciences Updates Investor Presentation and Pipeline Outlook - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQSkEwRXFPaDh2VTFFQkYtTnNOdktYTDkzeHQ4RkxfbjM0Y0JVU3BLVGloZGMzTnRVQW1FYzYxZnExOGVaVWQyMmNkZk9Lcm9kb0VZZHNKUFlqcUVtcE05UmI0ZmJETDBuSkVwV0l0SFlKajl5Z0dtUktDRUxScklLczVpM25SeGlOaVdBVzNDQXhxUlNZRklGSXp4UGNHRExjemdDM1NmUVRfb3kxMENuNGNuLW4xakQ2X2RMV2JUSQ?oc=5","Mon, 28 Sep 2026 21:44:46 GMT","Inhibrx Biosciences Updates Investor Presentation and Pipeline Outlook TipRanks","TipRanks"]